Phase III evaluating the addition of fulvestrant (F) to anastrozol (A) as adjuvant therapy in postmenopausal women with hormone receptor positive HER2 negative (HR+/HER2-) early breast cancer (EBC): Results from the GEICAM/2006-10 study
Por:
Ruiz-Borrego, M, Jimenez, MM, Ruiz, A, Lluch, A, Ramos, M, Jurado, JC, Baena-Canada, JM, Cirauqui, B, Rodriguez-Lescure, A, Conejo, EA, Janez, NM, Munoz, M, Antolin, S, Lopez, IA, Del Barco, S, Garcia-Estevez, L, Lopez-Muniz, JIC, Torres, AA and Carrasco, E
Publicada:
1 sep 2017
Resumen:
Filiaciones:
Ruiz-Borrego, M:
Hosp Virgen del Rocio, Oncol, Seville, Spain
Jimenez, MM:
Hosp Gen Univ Gregorio Maranon, GEICAM, CIBERONC, Med Oncol, Madrid, Spain
Ruiz, A:
Inst Valenciano Oncol, Clin Oncol, Valencia, Spain
Lluch, A:
Hosp Clin Univ Valencia, Med Oncol, Valencia, Spain
Ramos, M:
Ctr Oncol Galicia, Med Oncol, La Coruna, Spain
Jurado, JC:
Hosp Univ Canarias, Clin Oncol, San Cristobal La Laguna, Spain
Baena-Canada, JM:
Hosp Univ Puerta del Mar, Clincal Oncol, Cadiz, Spain
:
Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol Badalona, Clincal Oncol, Badalona, Spain
Rodriguez-Lescure, A:
HGH Elche, Med Oncol, Elche Alicante, Spain
Conejo, EA:
Hosp Univ Virgen de la Victoria, Clin Oncol, GEICAM, CIBERONC, Malaga, Spain
Janez, NM:
Hosp Univ Ramon & Cajal, Med Oncol, Madrid, Spain
Munoz, M:
12H Clin & Prov Barcelona, Clin Oncol, Barcelona, Spain
Antolin, S:
13Complejo Hosp Univ A Coruna, Clin Oncol, Coruna, Spain
Lopez, IA:
Hosp Univ Donostia, Med Oncol, Donostia San Sebastian, Spain
Del Barco, S:
15Inst Catalan Oncol Girona, Clin Oncol, Girona, Spain
Garcia-Estevez, L:
Ctr Integral Oncol Clara Campal, Med Oncol, Madrid, Spain
Lopez-Muniz, JIC:
Hosp Virgen de la Salud, Clin Oncol, Toledo, Spain
Torres, AA:
Hosp Miguel Servet, Clin Oncol, Zaragoza, Spain
Carrasco, E:
GEICAM, Madrid, Spain
|